"10.1371_journal.pone.0115765","plos one","2014-12-31T00:00:00Z","Jason S Cheng; Ryan Craft; Gui-Qiu Yu; Kaitlyn Ho; Xin Wang; Geetha Mohan; Sergey Mangnitsky; Ravikumar Ponnusamy; Lennart Mucke","Gladstone Institute of Neurological Disease, San Francisco, California, United States of America; Department of Neurological Surgery, University of California San Francisco, San Francisco, California, United States of America; Department of Neurology, University of California San Francisco, California, United States of America; Department of Radiology and Biomedical Imaging, University of California San Francisco, San Francisco, California, United States of America","Conceived and designed the experiments: JC GY GM SM RP LM. Performed the experiments: JC RC GY XW KH GM SM. Analyzed the data: JC SM RP LM. Contributed reagents/materials/analysis tools: SM. Wrote the paper: JC LM.","LM has received research funding from Bristol-Myers Squibb and has served on the scientific advisory board of iPierian. He is a co-inventor on patent applications/patents relating to tau reduction that are owned by the Gladstone Institutes (U.S. Patent Publication Number 20120198573; U.S. Patent Publication Number 20140065206; and EP Patent No. 2145014), all of which are entitled “Agents that Reduce Neuronal Overexcitation”. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.","2014","12","Jason S Cheng","JSC",9,TRUE,6,7,4,2,TRUE,TRUE,FALSE,0,NA,FALSE
